COVID-19 presents special challenges for physicians who treat lung cancer patients. Julie Brahmer, MD, spoke with Healio recently about what physicians need to know about lung cancer care during the pandemic.
Dr. Brahmer is a member of LCRF’s Scientific Advisory Board and Professor of Oncology at Johns Hopkins University School of Medicine.
Despite the current public health crisis, Dr. Brahmer sees hope for the future.
“Over the past couple of months, we’ve had even more options for treatment for lung cancer approved by the FDA and that continues to give us great hope for improving survival and improving their quality of life when diagnosed with lung cancer,” she said.